Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck
Podcast
The deal before the deal
Big Pharma dealmaking has picked up, but the biotech path to a signed agreement is still anything but simple.
Ayla Ellison
,
James Waldron
Jun 26, 2026 9:20am
BIO 2026: How a gut feeling transformed cancer treatment forever
Jun 25, 2026 9:23am
Merck anti-TL1A antibody from Prometheus buy passes ph. 3 test
Jun 22, 2026 10:17am
Fierce Pharma
Lilly, Boehringer slash investment plans in Germany
Jun 3, 2026 3:10pm
Fierce Pharma
Merck goes with Google for AI push, strikes $1B enterprise deal
Apr 22, 2026 10:12am
Fierce Pharma
Merck's Welireg surprisingly fails in first-line kidney cancer
Apr 21, 2026 10:00am